Literature DB >> 20672244

Sickness absence and full return to work after cancer: 2-year follow-up of register data for different cancer sites.

Corné A Roelen1, Petra C Koopmans, Johan W Groothoff, Jac J van der Klink, Ute Bültmann.   

Abstract

OBJECTIVE: Cancer survival has improved in recent years, but data on return to work (RTW) after cancer are sparsely published. Therefore, this study analysed RTW after cancer.
METHODS: Employees diagnosed with breast cancer, genital cancer, gastro-intestinal cancer, lung cancer, skin cancer, or blood malignancies were selected from an occupational health register. Sickness absence was followed for 2 years after diagnosis and full RTW at equal earnings as before sickness absence was assessed for each cancer site using Cox proportional hazards regression analysis stratifying for age and gender.
RESULTS: 3701 (73%) of 5074 employees with cancer had full RTW after a median duration of 290 days. Employees with lung cancer had the longest duration of sickness absence and only 45% of them had full RTW 2 years after diagnosis compared with 88% of employees with genital cancer and 87% of employees with skin cancer. Age was associated with the time to full RTW among employees with genital cancer: women aged≥35 years had a longer time to full RTW compared with women <35 years and men aged≥55 years had a longer time to full RTW compared with men <35 years. Gender was associated with the time to full RTW among survivors of blood malignancies with women having a longer time to full RTW than men.
CONCLUSIONS: Most employees had full RTW within 2 years after the diagnosis of cancer and the time to RTW was largely independent of age and gender.
Copyright © 2010 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2010        PMID: 20672244     DOI: 10.1002/pon.1820

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  25 in total

1.  Prognostic factors of work disability in sick-listed cancer survivors.

Authors:  Peter van Muijen; Saskia F A Duijts; Allard J van der Beek; Johannes R Anema
Journal:  J Cancer Surviv       Date:  2013-06-26       Impact factor: 4.442

2.  Predictors of return to work in cancer survivors in the Royal Air Force.

Authors:  Kenneth Murray; Kin Bong Hubert Lam; David C McLoughlin; Steven S Sadhra
Journal:  J Occup Rehabil       Date:  2015-03

Review 3.  Quality of working life issues of employees with a chronic physical disease: a systematic review.

Authors:  Merel de Jong; Angela G E M de Boer; Sietske J Tamminga; Monique H W Frings-Dresen
Journal:  J Occup Rehabil       Date:  2015-03

4.  Breast cancer survivors: return to work and wage loss in selected hospitals in Malaysia.

Authors:  T T Su; M Azzani; F L Tan; S Y Loh
Journal:  Support Care Cancer       Date:  2017-12-05       Impact factor: 3.603

5.  Sick leave and disability pension in Hodgkin lymphoma survivors by stage, treatment, and follow-up time--a population-based comparative study.

Authors:  I Glimelius; S Ekberg; J Linderoth; M Jerkeman; E T Chang; M Neovius; K E Smedby
Journal:  J Cancer Surviv       Date:  2015-02-18       Impact factor: 4.442

6.  Return to work in European Cancer survivors: a systematic review.

Authors:  Sara Paltrinieri; Stefania Fugazzaro; Lucia Bertozzi; Maria Chiara Bassi; Martina Pellegrini; Massimo Vicentini; Elisa Mazzini; Stefania Costi
Journal:  Support Care Cancer       Date:  2018-05-29       Impact factor: 3.603

7.  Predictors of post-cancer diagnosis resignation among Japanese cancer survivors.

Authors:  Motoki Endo; Go Muto; Yuya Imai; Kiyomi Mitsui; Katsuji Nishimura; Kazuhiko Hayashi
Journal:  J Cancer Surviv       Date:  2019-11-13       Impact factor: 4.442

8.  Lost workdays in uterine cervical cancer survivors compared to the general population: impact of treatment and relapse.

Authors:  Åsa H Everhov; Sara Ekberg; Angelica Lindén Hirschberg; Karin Bergmark; Angelique Flöter Rådestad; Ingrid Glimelius; Karin E Smedby
Journal:  J Cancer Surviv       Date:  2015-11-12       Impact factor: 4.442

9.  Cancer Survivors' Social Context in the Return to Work Process: Narrative Accounts of Social Support and Social Comparison Information.

Authors:  M Armaou; L Schumacher; E A Grunfeld
Journal:  J Occup Rehabil       Date:  2018-09

10.  Type of hematological malignancy is crucial for the return to work prognosis: a register-based cohort study.

Authors:  Trine Allerslev Horsboel; Claus Vinther Nielsen; Bendt Nielsen; Chris Jensen; Niels Trolle Andersen; Annette de Thurah
Journal:  J Cancer Surviv       Date:  2013-08-15       Impact factor: 4.442

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.